Labetalol is a commonly used antihypertensive agent with potent alphaand beta-adrenoceptor blocking properties. Since its inroduction into clinical practice, there have been several reports of its interference in the measurement of urinary catecholamines and their metabolites (Harris & Richards 1977 , Miano et al. 1979 , Richards et al. 1979 , Hamilton et al. 1978 , Kobayashi et al. 1978 .
Factitiously raised values have been reported from the urine of patients on labetalol using fluorimetric as well as spectrophotometric analyses. We describe a recent case where a hypertensive patient on labetalol underwent extensive investigations including an exploratory laparotomy in search of a phaeochromocytoma because of misleading urinary catecholamines levels.
Case report
In 1980, a 50-year-old warehouseman presented to his GP with a history of episodic headache and 'pounding in his ears'. He was found to be hypertensive and was treated with several antihypertensive agents including atenolol, methyldopa, hydralazine, labetalol and Navidrex-K. His blood pressure proved difficult to control and after frequent visits to his GP with episodes of feeling unwell, headache, palpitations, dizziness and sometimes flushing of the face, he was referred to his local hospital for investigations. He was duly admitted for exclusion of a phaeochromocytoma. On admission he was on labetalol 200 mg and hydralazine 25 mg, both four times daily, and Navidrex-K one tablet daily. Urinary catecholamine levels (by high pressure liquid chromatography and electrochemical detection) showed normal noradrenaline and dopamine levels, but elevated adrenaline levels at 432, 276 and 1412 nmol/24 hours (normal range 0-200) sug-'Case presented to Clinical Section, 8 February 1985.
Accepted 22 February 1985 2Present address: Oldchurch General Hospital, Romford, Essex gested the presence of a phaeochromocytoma. Although intravenous urography suggested a slightly enlarged left suprarenal gland, abdominal CT scan was essentially normal. Coeliac axis arteriography including R and L renal angiography was normal. On adrenal venography at the time of venous sampling, there was a suggestion of a relatively avascular area in the region of the left adrenal gland high up and just under the L hemidiaphragm. Finally labetalol was stopped for three days and three urine collections completed for repeat estimations of catecholamines, but the results were inconclusive. The patient proceeded to laparotomy where only normal adrenal glands were found. Some of the left suprarenal fat pad and edge of the adrenal were removed, but histology confirmed fatty tissue only with some adrenal cortex but no evidence of a phaeochromocytoma. Postoperatively, the patient had pulmonary emboli and had to be anticoagulated.
Following discharge his symptoms recurred. On referral to St Bartholomew's Hospital for further investigation, he was taking hydralazine (25 mg three times daily), labetalol (200mg'four times daily) and Burinex K. On this medication, three consecutive 24-hour urinary vanillylmandelic acid (VMA) estimations were 34,37 and 35 ,mol/24 hours (normal range 5-35) and metanephrine estimations were 2.0, 2.3 and 2.5 pmol/24 hours (normal range < 5). Drug interference in the metanephrine estimation was present, and significant results were obtained only after a modification to the usual spectrophotometric method (Lax et al. 1979) . Plasma catecholamines (HPLC.ECD, Bouloux et al. 1985) , taken when the patient was hypertensive (155/100 mmHg) and experiencing symptoms, were noradrenaline 2.05nmol/I (normal range 0.4-2.0) and adrenaline 0.40nmol/I (normal range <0.6). A large peak corresponding to labetalol was detected co-eluting with adrenaline on the chromatogram of plasma extract. Quantification of adrenaline was only possible after resolution of these adjacent peaks by alteration of the eluent composition. Plasma tumour markers were all negative and adrenal imaging with the radionuclide meta-iodobenzylguanidine (123I.MIBG), showed normal uptake within the adrenal and no extra-adrenal hot spots.
On the basis of these investigations a catecholamine-secreting tumour was confidently excluded as the cause of his symptoms, and the patient was discharged with a diagnosis of essential hypertension and a mild anxiety state. Phaeochromocytoma is a rare condition accounting for 0.1-1% of cases of hypertension (Manger & Gifford 1978) . Although sustained hypertension that is refractory to conventional therapy may be the presenting complaint, the diagnosis is most often suspected in the presence of paroxysmal hypertension in association with symptoms such as anxiety, malaise, palpitations, sweating and headache, as in our patient. Confirmation of the diagnosis is usually by biochemical means, characteristically by elevated urinary catecholamine, VMA or metanephrine excretion. Several techniques including intravenous urography, arteriography, venography and more recently CT scanning and MIBG scanning may then be used for tumour localization prior to excision. Since the decision to investigate patients with suspected phaeochromocytoma is so heavily dependent on the initial biochemical findings, factitious results can lead to unnecessary and costly investigations.
The therapeutic advantage of labetalol, a potent alphaand beta-adrenoceptor blocking agent, in the management of possible phaeochromocytoma, while theoretically attractive, seems offset by the unfortunate property of this drug to interfere directly with the very investigations which are essential in establishing the diagnosis. Although labetalol does not interfere with radioenzymatic methods for plasma or urinary catecholamine estimations, this technique is not available in routine laboratory practice where fluorimetric, spectrophotometric and HPLC-ECD methods are generally used. Since labetalol causes spurious elevation of catecholamines and their metabolites in these assays, in our opinion this drug should be withheld during investigations of phaeochromocytoma if serious difficulties in the interpretation of biochemical results are to be avoided. Richards A patient is described with a long-term history of abdominal symptoms in whom a biopsy of bilateral ankle ulcers on initial presentation had shown the presence of what, in retrospect, was granulomatous vasculitis, but the diagnosis of Crohn's disease was not established until 9 years later. Crohn's disease should be considered as the cause of abdominal symptoms in a patient with cutaneous granulomatous vasculitis.
Case report A 51-year-old grinder was admitted urgently in January 1984 with severe abdominal pain and vomiting. His past medical history extended over 9 years. In 1975 he had presented with left iliac fossa pain and loose stools (3 times daily). A striking feature at that time was bilateral ankle ulceration. This had begun the previous year with red tender areas which had subsequently ulcerated. There was no surrounding livedo reticularis. Haematological investigations showed a mild iron deficiency anaemia (11 g/dl) and an ESR of 56 mm/h (Westergren). A barium enema was normal. Skin biopsy revealed necrotizing vasculitis which was reported as consistent with polyarteritis nodosa. The skin lesions healed on prednisolone (20mg daily). One year later he sustained a myocardial infarction which was thought to reflect coronary arteritis. In 1979 he was seen with right iliac fossa pain but this settled on intravenous steroids and fluids and was not further investigated. However, his glucose tolerance was found to be abnormal and he was started on chlorpropamide. Prednisolone was reduced to 10mg daily. In 1981 he returned with intermittent diarrhoea. His bowels opened 3 times daily with liquid faeces but no blood or slime. Sigmoidoscopy revealed small mucosal polyps and biopsy showed nonspecific proctitis. A barium enema was declined. In 1982 he developed an ischiorectal abscess and a persistent sinus which necessitated operative treatment.
His abdominal symptoms and general condition on admission in January 1984 were serious enough to warrant exploratory laparotomy. Operation revealed 53 cm of thickened terminal ileum with perforation and a 300 ml pericolic abscess. A bypass ileocolic anastomosis was performed with a 'Accepted 24 January 1985 0141-0768/85/070589-02/S02.00/0
